Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
General Session
Speaker: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
###Speaker: Peter Campbell – The Wellcome Trust Sanger Inst
General Session
Speaker: Peter Campbell – The Wellcome Trust Sanger Inst
###Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA ### 1395145###Co-Chair###Professor of Medicine, Director of the Center for Blood Cancers Director of the Clinical Myeloma Pro###Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA###Co-Chair: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
General Session
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels
General Session
Speaker: Karin Vanderkerken, PhD (she/her/hers) – Vrije Universiteit Brusssels
### she/her/hersSpeaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA
General Session
Speaker: Madhav V. Dhodapkar, MD, MBBS (he/him/his) – Winship Cancer Institute, Emory University, Atlanta, GA, USA
### he/him/hisSpeaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
General Session
Speaker: Sigurdur Y. Kristinsson, MD, PhD – University of Iceland
###Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
General Session
Speaker: Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
###Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University
General Session
Speaker: Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University
###Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
General Session
Speaker: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
### he/him/hisSpeaker: Leif Bergsagel, MD – Mayo Clinic Arizona
General Session
Speaker: Leif Bergsagel, MD – Mayo Clinic Arizona
###Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
General Session
Panelist: Rafael Fonseca, MD – Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
### @@@ Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University ### 1441802###Panelist###Professor###Alfred Health-Monash University###Panelist: Andrew Spencer, MBBS FRACP, FRCPA, DM – Alfred Health-Monash University
### @@@ Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre ### 1395134###Panelist###Senior Scientist, Hematologist###Princess Margaret Cancer Centre###Panelist: Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre
### he/him/his @@@ Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona ### 1395120###Panelist###Associate Professor###Mayo Clinic Arizona###Panelist: Marta Chesi, PhD (she/her/hers) – Mayo Clinic Arizona
### she/her/hersCo-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
### @@@ Ioanna Tsatsou ### 1996608###Co-Chair#########Co-Chair: Ioanna Tsatsou
###Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Nursing & Allied Health Symposium
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
### @@@ Ioanna Tsatsou ### 1996608###Co-Chair#########Co-Chair: Ioanna Tsatsou
###Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
Nursing & Allied Health Symposium
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
### he/him/hisSpeaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Nursing & Allied Health Symposium
Speaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
###Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center
Nursing & Allied Health Symposium
Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center
###Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital
Nursing & Allied Health Symposium
Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital
###Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital
Nursing & Allied Health Symposium
Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital
###Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
Nursing & Allied Health Symposium
Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
Nursing & Allied Health Symposium
Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
### @@@ Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich ### 1409002###Co-Chair###Clinical Nurse Specialist###Comprehensive Cancer Center Zurich###Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
###Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust
Nursing & Allied Health Symposium
Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust
###Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom
Nursing & Allied Health Symposium
Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom
### she/her/hersSpeaker: Emma Dowling, RN BSC – HCA Healthcare UK
Nursing & Allied Health Symposium
Speaker: Emma Dowling, RN BSC – HCA Healthcare UK
###Speaker: Houry Leblebjian
Nursing & Allied Health Symposium
Speaker: Houry Leblebjian
###Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University
Nursing & Allied Health Symposium
Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University
###Industry Symposium
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
### he/him/hisSpeaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
Industry Symposium
Speaker: Hermann Einsele, MD, FRCP (he/him/his) – Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Würzburg, Germany
### he/him/hisSpeaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA
Industry Symposium
Speaker: Yi Lin, MD, PHD – Mayo Clinic, Rochester, MN, USA
###Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC
Industry Symposium
Speaker: Bruno Paiva, PhD – Clínica Universidad de Navarra (CUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC
###Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
Industry Symposium
Speaker: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
###Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
Industry Symposium
Chair: Rakesh Popat, MD, PhD – University College London Hospitals NHS Foundation Trust
###Nursing & Allied Health Symposium
Nursing & Allied Health Symposium
Co-Chair: Tiffany Richards
### @@@ Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health ### 1998508###Co-Chair###Myeloma Specialist Pharmacist / Head of Patient Innovation & Care###NHS / Sanius Health###Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health
### she/her/hersSpeaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
Nursing & Allied Health Symposium
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
###Speaker: Monica Morris, MSc, RN – Myeloma UK
Nursing & Allied Health Symposium
Speaker: Monica Morris, MSc, RN – Myeloma UK
###Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center
Nursing & Allied Health Symposium
Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center
### she/her/hersSpeaker: Rebecca Lu, MSN, FNP-C – MD Anderson
Nursing & Allied Health Symposium
Speaker: Rebecca Lu, MSN, FNP-C – MD Anderson
###Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
Nursing & Allied Health Symposium
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
###Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Chair: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
### she/her/hers @@@ S. Vincent Rajkumar, MD – Mayo Clinic ### 1949877###Co-Chair###Edward W. and Betty Knight Scripps Professor of Medicine###Mayo Clinic###Co-Chair: S. Vincent Rajkumar, MD – Mayo Clinic
###Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
General Session
Speaker: Saad Z. Usmani, MD MBA FACP – Memorial Sloan Kettering Cancer Center
###Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
General Session
Speaker: Aurore Perrot, MD, PhD – CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
###Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
General Session
Speaker: Kwee L. Yong, PhD (she/her/hers) – University College London Cancer Institute, London, UK
### she/her/hersSpeaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
General Session
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
### he/him/hisSpeaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital
General Session
Speaker: Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital
### he/him/hisSpeaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
General Session
Speaker: Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
### she/her/hersSpeaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
General Session
Speaker: Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
### he/him/hisSpeaker: S. Vincent Rajkumar, MD – Mayo Clinic
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
###Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
Panelist: Bindu Kanapuru
General Session
Panelist: Sergio Giralt, MD – Memorial Sloan Kettering Cancer Center
### @@@ Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France ### 1395081###Panelist###Pr###University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France###Panelist: Thierry Facon, MD – University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France
### @@@ Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE ### 1395104###Panelist###SCIENTIFIC DIRECTOR###INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE###Panelist: Jean-Luc Harousseau, MD – INSTITUT DE CANCEROLOGIE DE L'OUEST FRANCE
### @@@ Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil ### 1395161###Panelist###Associate Professor###Department of Hematology, Clinica São Germano, São Paulo, Brazil###Panelist: Vania Hungria, MD, PhD – Department of Hematology, Clinica São Germano, São Paulo, Brazil
### @@@ Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy ### 1395079###Panelist###Professor of Haematology###IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy###Panelist: Michele Cavo (he/him/his) – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Università degli Studi di Bologna, Bologna, Italy
### he/him/his @@@ Bindu Kanapuru ### 2102754###Panelist#########Panelist: Bindu Kanapuru
###Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Oral Abstract Session
Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
Oral Abstract Session
Co-Chair: Morie A. Gertz, MD, MACP (he/him/his) – Mayo Clinic
### he/him/his @@@ Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT) ### 1441836###Co-Chair###Head of the GMMG Studygroup, Department of Medicine V### Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)###Co-Chair: Hartmut Goldschmidt, MD – Department of Medicine V, University Hospital Heidelberg; and National Center for Tumor Diseases (NCT)
###Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
Oral Abstract Session
Speaker: Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
###Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
Oral Abstract Session
Speaker: Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
###Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine
Oral Abstract Session
Speaker: Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine
### he/him/hisSpeaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Oral Abstract Session
Speaker: Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
Oral Abstract Session
Speaker: Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
### he/him/hisCo-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
Oral Abstract Session
Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
Oral Abstract Session
Co-Chair: Annemiek Broijl, MD, PhD (she/her/hers) – ErasmusMC
### she/her/hers @@@ Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences. ### 1409100###Co-Chair###Department Head###Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.###Co-Chair: Lugui Qiu, MD (he/him/his) – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences.
### he/him/hisSpeaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute
Oral Abstract Session
Speaker: Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute
###Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia
Oral Abstract Session
Speaker: Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia
###Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center
Oral Abstract Session
Speaker: wei tan, Ph.D – The University of Texas MD Anderson Cancer Center
###Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
Oral Abstract Session
Speaker: Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine
### he/him/hisSpeaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Oral Abstract Session
Speaker: Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
### she/her/hersSpeaker: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Siddhartha Mukherjee
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
Speaker: Siddhartha Mukherjee
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
General Session
Speaker: S. Vincent Rajkumar, MD – Mayo Clinic
### @@@ Siddhartha Mukherjee ### 1957007###Speaker#########Speaker: Siddhartha Mukherjee
### @@@ Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA ### 1395113###Speaker###Professor and Chair###Emory University School of Medicine, Atlanta, GA, USA###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###